20 March 2024: Mainz Biomed hosts a webinar with Ganzimmun on early colorectal cancer detection, featuring its flagship product, ColoAlert®.
Mainz Biomed, a leader in molecular genetics diagnostic solutions for early cancer detection, hosts a webinar in collaboration with Ganzimmun on 20 March 2024. The webinar, titled "Early Detection of Colorectal Cancer: New Laboratory Diagnostic Options," educates pharmacists, physicians, and healthcare professionals on innovative lab diagnostic approaches, genetic markers, and advancements in screening techniques for accurate risk assessment and early detection. The event offers continuing education credits and promotes Mainz Biomed's flagship product, ColoAlert®, a non-invasive at-home colorectal cancer screening kit with high sensitivity and specificity.
March 18, 2024
5 Articles